GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lionco Pharmaceutical Group Co Ltd (SHSE:603669) » Definitions » Price-to-Free-Cash-Flow

Lionco Pharmaceutical Group Co (SHSE:603669) Price-to-Free-Cash-Flow : N/A (As of Apr. 30, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Lionco Pharmaceutical Group Co Price-to-Free-Cash-Flow?

As of today (2024-04-30), Lionco Pharmaceutical Group Co's share price is ¥4.75. Lionco Pharmaceutical Group Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.08. Hence, Lionco Pharmaceutical Group Co's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Lionco Pharmaceutical Group Co's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Lionco Pharmaceutical Group Co's highest Price-to-Free-Cash-Flow Ratio was 313.81. The lowest was 16.85. And the median was 78.85.

SHSE:603669's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.08
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Lionco Pharmaceutical Group Co's Free Cash Flow per Share for the three months ended in Mar. 2024 was ¥-0.03. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ¥-0.08.

During the past 13 years, Lionco Pharmaceutical Group Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 81.10% per year. The lowest was -27.70% per year. And the median was 5.70% per year.


Lionco Pharmaceutical Group Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Lionco Pharmaceutical Group Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lionco Pharmaceutical Group Co Price-to-Free-Cash-Flow Chart

Lionco Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.79 101.41 98.91 - -

Lionco Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lionco Pharmaceutical Group Co's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Lionco Pharmaceutical Group Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lionco Pharmaceutical Group Co's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lionco Pharmaceutical Group Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Lionco Pharmaceutical Group Co's Price-to-Free-Cash-Flow falls into.



Lionco Pharmaceutical Group Co Price-to-Free-Cash-Flow Calculation

Lionco Pharmaceutical Group Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=4.75/-0.077
=N/A

Lionco Pharmaceutical Group Co's Share Price of today is ¥4.75.
Lionco Pharmaceutical Group Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.08.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Lionco Pharmaceutical Group Co  (SHSE:603669) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Lionco Pharmaceutical Group Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Lionco Pharmaceutical Group Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Lionco Pharmaceutical Group Co (SHSE:603669) Business Description

Traded in Other Exchanges
N/A
Address
68 Zetang Nedong commercial building, 2nd Floor, Shannan Prefecture, CHN
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.

Lionco Pharmaceutical Group Co (SHSE:603669) Headlines

No Headlines